The α4β7 blockade with vedolizumab is effective in prevention of graft vs. host disease using a xenogeneic mouse model
Senthilnathan Palaniyandi1, Reena Kumari1, Ethan Strattan1,2
1Department of Internal Medicine, Markey Cancer Center, Division of Hematology & Blood and Marrow Transplantation, University of Kentucky, Lexington, Kentucky.
American Journal of Hematology
|November 15, 2019
Abstract
No abstract available in PubMed .


